Stomach cancer trial combines chemo and Bacteria-Fighting therapy
NCT ID NCT06510010
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This study tests whether adding H. pylori bacteria treatment to standard chemotherapy before and after surgery can improve outcomes for people with stomach or gastroesophageal junction cancer. About 198 adults with H. pylori-positive, locally advanced cancer will be randomly assigned to receive either chemotherapy alone or chemotherapy plus H. pylori eradication. The main goal is to see if the combination leads to a better tumor response after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Sixth Affiliated Hospital，Sun Yat-sen University
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.